However, given the intratumoral heterogeneity and discrepancy of PD-L1 expression between primary and metastatic lesions, PD-L1 expression does not reflect the entire tumor microenvironment and sometimes was not subject to reliable biomarker in mRCC [11]. This evidence concerns the gene CD274 and neoplasm.